News Conference News AHA 2024 GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes Michael O'Riordan November 17, 2024
News Daily News Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data Michael O'Riordan November 07, 2024
News Conference News TCT 2024 CONFIRM2 Shows Power of AI-QCT to Use Plaque Features to Predict CAD Events Yael L. Maxwell November 01, 2024
Presentation TCT 2024 TCT 1014: Lipid-Rich Non-Culprit Lesions Demonstrate Less Favorable Changes in Plaque Volume During the First Weeks After ACS Presenter: Jonathan Los October 29, 2024
Presentation TCT 2024 Changes in Plaque Volume and Plaque Composition After 12 Weeks of Extensive LDL-C Reduction With PCSK9 Inhibitors in ACS Patients With Multivessel Disease Presenter: Jonathan Los October 27, 2024
News Conference News SCCT 2024 AI Assessment of Plaque, Hemodynamics May ID Lesion-Specific ACS Risk Todd Neale July 25, 2024
News Conference News EuroPCR 2024 OCT-Based Strategy Outperforms Angiography in Calcified Lesions: CALIPSO Caitlin E. Cox May 16, 2024
Presentation THT Abstracts 2024 Longitudinal Near-Infrared Spectroscopy Intravascular Ultrasound Assessment of Donor-transmitted Lipid Content and Plaque Volume in Coronary Arteries after Heart Transplantation Presenter: Tatsuya Shiraki March 05, 2024
News Daily News Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest Michael O'Riordan January 30, 2024